Abstract:Objective. To explore the significance of magnetic resonance imaging (MRI) combining with detection of serum HE4, TSGF, and CD105 levels in diagnosis and treatment of moderate to advanced cervical cancer. Methods. By means of retrospective study, 50 patients diagnosed with moderate to advanced cervical cancer by cervix biopsy pathology examination in our hospital from October 2018 to October 2019 were selected as the study group, and another 50 healthy individuals who did not have cervical cancer after routine gynecological examination and conventional ultrasound examination in the same period were selected as the control group. At the time of enrollment and 3 months after treatment, all study subjects received MRI examination and serological examination, and their HE4 and TSGF levels were measured by the enzyme-linked immunosorbent assay (ELISA) and chromatography method, respectively, and additionally, the immunohistochemistry SP method was adopted for patients in the study group to measure the microvessel density (MVD) marked by CD105. The relationship between MRI staging and FIGO staging was assessed, the efficacy of combining MRI with detection of serum HE4, TSGF, and CD105 levels in diagnosing moderate to advanced cervical cancer was calculated by plotting the ROC curve, and the imaging changes and serological changes of tumor tissue before and after treatment were analyzed. Results. There were 3 of 4 patients in stage IIa and 14 of 15 patients in stage IIIb presenting MRI findings compatible with clinical examinations; 26 patients in stage IIb and 5 patients in stage IVb presenting MRI findings totally compatible with clinical examination. Before treatment, MRI finding of cervical lesion was irregular soft tissue mass, T1WI appeared isointensity or hyperintensity, and obvious lesion enhancement could be seen by enhanced scan. T2WI appeared mixed signal intensity or hyperintensity, with necrotic tissue and fat suppression being hyperintensity. After treatment, lesions shrunk, originally abnormal signals in 5 patients disappeared, and T1WI and T2WI signals in 45 patients presented no difference compared to before treatment. After T1WI enhancement, mild enhancement could be seen in 41 cases and no enhancement in 4 cases. The CD105-MVD of the study group was (68.98 ± 5.23); before and after treatment, the differences in HE4 and TSGF levels between the study group and the control group were significant ( P < 0.001 ). The sensitivity, specificity, and accuracy rate of diagnosis of MRI diagnosis were respectively 82.0% (41/50), 90.0% (45/50), and 86.0% (86/100), and for the diagnosis combining with serum HE4, TSGF, and CD105 levels, they were 96.0% (48/50), 96.0% (48/50), and 96.0% (96/100), respectively, and AUC (95% CI) = 0.960 (0.908–1.000). Conclusion. MRI staging is objective and accurate and has higher sensitivity when combined with serum HE4, TSGF, and CD105 levels in diagnosing moderate to advanced cervical cancer. All MRI, HE4, and TSGF can reflect the treatment effect of patients and are of great importance to efficacy assessment.

Comparison of Imaging Features and Diagnostic Values of MRI, CT and Contrast-Enhanced Ultrasonography in the Diagnosis of Cervical Carcinoma Staging

MRI features and value of new staging in cervical carcinoma

Contrast Analysis of CT Perfusion Imaging Staging and FIGO Staging and Pathological Staging of Cervical Carcinoma

MRI is More Valuable Than CT in the Diagnosis of Cervical Cancer.

Accuracy of 1.5T MRI in Determining the Resectability of Cervical Cancer

&Lt;p>impact of Pelvic MRI in Routine Clinical Practice on Staging of IB1&ndash;IIA2 Cervical Cancer</p>

MRI Diagnosis and Staging of Cervical Carcinoma

Values of MRI Dynamic Contrast-Enhanced Imaging for Diagnosis and Staging of Cervical Cancer

Application of MRI in the Diagnosis of Cervical Cancer

Accuracy of Magnetic Resonance Imaging in Assessing Myometrium Invasion and Preoperative Staging of Endometrial Carcinoma

MRI Features and Staging of Cervical Carcinoma

Comparative Study of Contrast-enhanced Ultrasound vs.Conventional Ultrasound in Preoperative Diagnosis and Clinical Stage of Cervical Cancer

Application of 3.0 T multimodal MRI in FIGO staging of cervical cancer

The Value of Magnetic Resonance Imaging on Diagnose Stage of Cervical Cancer

Comparative the Clinical Value of Contrast-Enhanced Ultrasonography, Enhancement CT and MRI for Diagnosing of Liver Lesions.

Comparative Study Between MRI Features and Pathology in FIGO Stage I and II Endometrial Carcinoma

Significance of Magnetic Resonance Imaging Combining with Detection of Serum HE4, TSGF, and CD105 Levels in Diagnosis and Treatment of Moderate to Advanced Cervical Cancer

Value of CT Combined with MRI in the Diagnosis and Staging of Endometrial Cancer

The Value of MRI in Diagnosis and Staging of Endometrial Carcinoma

The diagnostic value of multimodality MRI in endometrial carcinoma staging

Comparison of MRI features among squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma, usual-type endocervical adenocarcinoma and gastric adenocarcinoma of cervix